Presentation is loading. Please wait.

Presentation is loading. Please wait.

High-Risk Mitral Valve Surgery: Perioperative Hemodynamic Optimization with Nesiritide (BNP)  Sacha P. Salzberg, MD, Farzan Filsoufi, MD, Anelechi Anyanwu,

Similar presentations


Presentation on theme: "High-Risk Mitral Valve Surgery: Perioperative Hemodynamic Optimization with Nesiritide (BNP)  Sacha P. Salzberg, MD, Farzan Filsoufi, MD, Anelechi Anyanwu,"— Presentation transcript:

1 High-Risk Mitral Valve Surgery: Perioperative Hemodynamic Optimization with Nesiritide (BNP) 
Sacha P. Salzberg, MD, Farzan Filsoufi, MD, Anelechi Anyanwu, MD, Kai von Harbou, MD, Alan Gass, MD, Sean P. Pinney, MD, Alain Carpentier, MD, PhD, David H. Adams, MD  The Annals of Thoracic Surgery  Volume 80, Issue 2, Pages (August 2005) DOI: /j.athoracsur Copyright © 2005 The Society of Thoracic Surgeons Terms and Conditions

2 Fig 1 Changes in pulmonary artery pressures and central venous pressure during treatment with brain-type natriuretic peptide (n = 14). ♦ = pulmonary arterial; ■ = pulmonary capillary wedge pressures; ▴ = central venous pressure. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2005 The Society of Thoracic Surgeons Terms and Conditions

3 Fig 2 Hemodynamic recordings, heart rate, and cardiac output. (bpm = beats per minute; ICU = intensive care unit; OR = operating room.) The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2005 The Society of Thoracic Surgeons Terms and Conditions


Download ppt "High-Risk Mitral Valve Surgery: Perioperative Hemodynamic Optimization with Nesiritide (BNP)  Sacha P. Salzberg, MD, Farzan Filsoufi, MD, Anelechi Anyanwu,"

Similar presentations


Ads by Google